Impact of the life sciences on organisation and management of R&D in large pharmaceutical firms

ISSN： 0963-6048

Source： International Journal of Biotechnology, Vol.10, Iss.5, 2008-11, pp. : 416-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Will genomics revolutionise pharmaceutical R&D?

By Noble D.

Trends in Biotechnology, Vol. 21, Iss. 8, 2003-08 ,pp. : 333-337

Elsevier

Access to resources Recommend Favorite

Rethinking innovation in pharmaceutical R&D

By Baker Ann Gill Jasween

Journal of Commercial Biotechnology, Vol. 12, Iss. 1, 2005-10 ,pp. : 45-49

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Editorial: R&D in biotechnology – The management challenges

By Shohet Simon

Journal of Commercial Biotechnology, Vol. 10, Iss. 4, 2004-06 ,pp. : 301-303

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Biotechnology and pharmaceutical R&D and licensing trends: You pays your money and takes your chances

By Ratliff Alan

Journal of Commercial Biotechnology, Vol. 10, Iss. 1, 2003-09 ,pp. : 54-59

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

R&D spending and sources of funding of private US biopharmaceutical firms seeking to go public

By Williams David R Pouder Richard W

Journal of Commercial Biotechnology, Vol. 16, Iss. 4, 2010-10 ,pp. : 284-292

Palgrave Macmillan Ltd

Access to resources Recommend Favorite